1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
Give ME the Money
Graham McPhee spells out some of the cold, hard facts about the dismal state of ME research and politics, and has some suggestions as to what we can do about it ...
Discuss the article on the Forums.

growth hormone and thyrotropin-releasing hormone therapy?

Discussion in 'General Treatment' started by aquariusgirl, Sep 23, 2010.

  1. aquariusgirl

    aquariusgirl Senior Member

    Messages:
    951
    Likes:
    92
    Ji
    Has anyone heard of anyone supplementing with the above hormones instead of downstream ones, ?

    The following is taken from a site about mercury toxicity.. but touches on this hormone therapy.

    thanks



    Another neurological effect of mercury that occurs at very low levels is inhibition of nerve growth factors, for which deficiencies result in nerve degeneration. Mercury vapor is lipid soluble and has an affinity for red blood cells and CNS cells(21a). Only a few micrograms of mercury severely disturb cellular function and inhibits nerve growth (175,147,226,255,305,149). Prenatal or neonatal exposures have been found to have life long effects on nerve function and susceptibility to toxic effects. Prenatal mercury vapor exposure that results in levels of only 4 parts per billion in newborn rat brains was found to cause decreases in nerve growth factor and other effects(305). This is a level that is common in the population with several amalgam fillings or other exposures(500). Insulin-like-growth factor I (IGF-I) are positively correlated with growth hormone levels and have been found to be the best easily measured marker for levels of growth hormone, but males have been found more responsive to this factor than women(497). IGF-I controls the survival of spinal motor neurons affected in ALS during development as well as later in life(497,498). IGF-I and insulin levels have been found to be reduced in ALS patients with evidence this is a factor in ALS(497,498). Several clinical trials have found IGF-I treatment is effective at reducing the damage and slowing the progression of ALS and Alzheimers with no medically important adverse effects(498


    ]It has also been found that in chronically ill patients the levels of pituitary and thyroid hormones that control many bodily processes are low, and that supplementing both thyrotropin-releasing hormone and growth control hormone is more effective at increasing all of these hormone levels in the patient(499). [/I][/B][/U]

    http://www.flcv.com/amalg6.html
     
  2. voner

    voner Senior Member

    Messages:
    237
    Likes:
    151
    I not only had my Mercury algum fillings replaced, but also I did a six-month trial of hgh (Omnitrope). Replacing the fillings had no effect on my symptoms. The only thing the Omnitrope did for me was to further disturb my sleep - which I didn't realize until I went off the Omnitrope. Kind of counterintuitive to me, but that's what happened. I was kind of gung ho on trying hgh for a long time -- I used to follow the research of Robert Bennett from the University of Oregon - who did a lot of research on fibromyalgia and they explored the connection between hgh and somatostatin…. eventually they gave up on it -- I think…. it certainly iwas an expensive option for me – my insurance wouldn't cover that sort of experiment….
     

See more popular forum discussions.

Share This Page